???pagination.result.count???
???pagination.result.page???
1
Cellular responses in the FGF10-mediated improvement of hindlimb regenerative capacity in Xenopus laevis revealed by single-cell transcriptomics. , Yanagi N., Dev Growth Differ. August 1, 2022; 64 (6): 266-278.
Id genes are essential for early heart formation. , Cunningham TJ., Genes Dev. July 1, 2017; 31 (13): 1325-1338.
Smad1 transcription factor integrates BMP2 and Wnt3a signals in migrating cardiac progenitor cells. , Song J., Proc Natl Acad Sci U S A. May 20, 2014; 111 (20): 7337-42.
Macrophage Wnt7b is critical for kidney repair and regeneration. , Lin SL., Proc Natl Acad Sci U S A. March 2, 2010; 107 (9): 4194-9.
Cell-cell interactions during remodeling of the intestine at metamorphosis in Xenopus laevis. , Schreiber AM ., Dev Biol. July 1, 2009; 331 (1): 89-98.
FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression. , Chen PY., J Biol Chem. June 5, 2009; 284 (23): 15980-92.
Induction and modulation of smooth muscle differentiation in Xenopus embryonic cells. , Barillot W., Dev Dyn. November 1, 2008; 237 (11): 3373-86.
Opposite effects of FGF and BMP-4 on embryonic blood formation: roles of PV.1 and GATA-2. , Xu RH., Dev Biol. April 15, 1999; 208 (2): 352-61.
Activation of smooth muscle alpha-actin promoter in ras-transformed cells by treatments with antimitotic agents: correlation with stimulation of SRF:SRE mediated gene transcription. , Kumar CC., J Biochem. December 1, 1995; 118 (6): 1285-92.
SCH 51344 inhibits ras transformation by a novel mechanism. , Kumar CC., Cancer Res. November 1, 1995; 55 (21): 5106-17.
Effect of an inhibitory mutant of the FGF receptor on mesoderm-derived alpha- smooth muscle actin-expressing cells in Xenopus embryo. , Saint-Jeannet JP ., Dev Biol. August 1, 1994; 164 (2): 374-82.
Mesoderm induction in amphibians: the role of TGF-beta 2-like factors. , Rosa F., Science. February 12, 1988; 239 (4841 Pt 1): 783-5.